Cargando…

N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets

BACKGROUND: A tremendous amount of studies have suggested that post-translational modifications (PTMs) play pivotal roles during tumorigenesis. Compared to other PTMs, lipid modification is less studied. Recently, N-myristoylation, one type of lipid modification, has been paid attention to the field...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Guoqing, Wang, Feng, Li, Haojie, Zhang, Xiao, Wu, Qi, Liu, Ya, Qian, Mingping, Guo, Susu, Yang, Yueyue, Xue, Xiangfei, Sun, Fenyong, Qiao, Yongxia, Pan, Qiuhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201403/
https://www.ncbi.nlm.nih.gov/pubmed/34136404
http://dx.doi.org/10.3389/fonc.2021.681366
_version_ 1783707811269574656
author Zhu, Guoqing
Wang, Feng
Li, Haojie
Zhang, Xiao
Wu, Qi
Liu, Ya
Qian, Mingping
Guo, Susu
Yang, Yueyue
Xue, Xiangfei
Sun, Fenyong
Qiao, Yongxia
Pan, Qiuhui
author_facet Zhu, Guoqing
Wang, Feng
Li, Haojie
Zhang, Xiao
Wu, Qi
Liu, Ya
Qian, Mingping
Guo, Susu
Yang, Yueyue
Xue, Xiangfei
Sun, Fenyong
Qiao, Yongxia
Pan, Qiuhui
author_sort Zhu, Guoqing
collection PubMed
description BACKGROUND: A tremendous amount of studies have suggested that post-translational modifications (PTMs) play pivotal roles during tumorigenesis. Compared to other PTMs, lipid modification is less studied. Recently, N-myristoylation, one type of lipid modification, has been paid attention to the field of cancer. However, whether and how N-myristoylation exerts its roles in liver tumorigenesis still remains unclear. METHODS: Parallel reaction monitoring (PRM) was conducted to evaluate the expression of protein modification enzymes in paired tissues. Liver conditionally knocking NMT1 out mice model was used to assess the critical roles of N-myristoylation during liver tumorigenesis. Proteomics isobaric tags for relative and absolute quantification (iTraq) was performed to identify proteins that changed while NMT1 was knocked down. The click chemistry assay was used to evaluate the N-myristoylation levels of proteins. RESULTS: Here, N-myristolyation and its enzyme NMT1, but not NMT2, were found to be critical in liver cancer. Two categories of proteins, i.e., N-myristolyation down-regulated proteins (NDP, including LXN, RPL29, and FAU) and N-myristolyation up-regulated proteins (NUP, including AHSG, ALB, and TF), were revealed negatively and positively regulated by NMT1, respectively. Both NDP and NUP could be N-myristolyated by NMT1 indispensable of POTEE. However, N-myristolyation decreased and increased stability of NDP and NUP, respectively. Mechanistically, NDP-specific binding protein RPL7A facilitated HIST1H4H, which has ubiquitin E3 ligase function, to ubiquitinate NDP. By contrast, NUP-specific binding protein HBB prevented NUP from ubiquitination by HIST1H4H. Notably, function of RPL7A and HBB was all NMT1-dependent. Moreover, NDP suppressed while NUP stimulated transformative phenotypes. Clinically, higher levels of NMT1 and NUP with lower levels of NDP had worse prognostic outcome. CONCLUSION: Collectively, N-myristolyation by NMT1 suppresses anti-tumorigenic NDP, whereas it stimulates pro-tumorigenic NUP by interfering their ubiquitination to finally result in a pro-tumorigenic outcome in liver cancer. Targeting N-myristolyation and NMT1 might be helpful to treat liver cancer.
format Online
Article
Text
id pubmed-8201403
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82014032021-06-15 N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets Zhu, Guoqing Wang, Feng Li, Haojie Zhang, Xiao Wu, Qi Liu, Ya Qian, Mingping Guo, Susu Yang, Yueyue Xue, Xiangfei Sun, Fenyong Qiao, Yongxia Pan, Qiuhui Front Oncol Oncology BACKGROUND: A tremendous amount of studies have suggested that post-translational modifications (PTMs) play pivotal roles during tumorigenesis. Compared to other PTMs, lipid modification is less studied. Recently, N-myristoylation, one type of lipid modification, has been paid attention to the field of cancer. However, whether and how N-myristoylation exerts its roles in liver tumorigenesis still remains unclear. METHODS: Parallel reaction monitoring (PRM) was conducted to evaluate the expression of protein modification enzymes in paired tissues. Liver conditionally knocking NMT1 out mice model was used to assess the critical roles of N-myristoylation during liver tumorigenesis. Proteomics isobaric tags for relative and absolute quantification (iTraq) was performed to identify proteins that changed while NMT1 was knocked down. The click chemistry assay was used to evaluate the N-myristoylation levels of proteins. RESULTS: Here, N-myristolyation and its enzyme NMT1, but not NMT2, were found to be critical in liver cancer. Two categories of proteins, i.e., N-myristolyation down-regulated proteins (NDP, including LXN, RPL29, and FAU) and N-myristolyation up-regulated proteins (NUP, including AHSG, ALB, and TF), were revealed negatively and positively regulated by NMT1, respectively. Both NDP and NUP could be N-myristolyated by NMT1 indispensable of POTEE. However, N-myristolyation decreased and increased stability of NDP and NUP, respectively. Mechanistically, NDP-specific binding protein RPL7A facilitated HIST1H4H, which has ubiquitin E3 ligase function, to ubiquitinate NDP. By contrast, NUP-specific binding protein HBB prevented NUP from ubiquitination by HIST1H4H. Notably, function of RPL7A and HBB was all NMT1-dependent. Moreover, NDP suppressed while NUP stimulated transformative phenotypes. Clinically, higher levels of NMT1 and NUP with lower levels of NDP had worse prognostic outcome. CONCLUSION: Collectively, N-myristolyation by NMT1 suppresses anti-tumorigenic NDP, whereas it stimulates pro-tumorigenic NUP by interfering their ubiquitination to finally result in a pro-tumorigenic outcome in liver cancer. Targeting N-myristolyation and NMT1 might be helpful to treat liver cancer. Frontiers Media S.A. 2021-05-31 /pmc/articles/PMC8201403/ /pubmed/34136404 http://dx.doi.org/10.3389/fonc.2021.681366 Text en Copyright © 2021 Zhu, Wang, Li, Zhang, Wu, Liu, Qian, Guo, Yang, Xue, Sun, Qiao and Pan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhu, Guoqing
Wang, Feng
Li, Haojie
Zhang, Xiao
Wu, Qi
Liu, Ya
Qian, Mingping
Guo, Susu
Yang, Yueyue
Xue, Xiangfei
Sun, Fenyong
Qiao, Yongxia
Pan, Qiuhui
N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets
title N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets
title_full N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets
title_fullStr N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets
title_full_unstemmed N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets
title_short N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets
title_sort n-myristoylation by nmt1 is potee-dependent to stimulate liver tumorigenesis via differentially regulating ubiquitination of targets
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201403/
https://www.ncbi.nlm.nih.gov/pubmed/34136404
http://dx.doi.org/10.3389/fonc.2021.681366
work_keys_str_mv AT zhuguoqing nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT wangfeng nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT lihaojie nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT zhangxiao nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT wuqi nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT liuya nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT qianmingping nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT guosusu nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT yangyueyue nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT xuexiangfei nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT sunfenyong nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT qiaoyongxia nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets
AT panqiuhui nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets